Proton pump inhibitors use and the risk of fatty liver disease: A nationwide cohort study.
Jeung Hui PyoTae Jun KimHyuk LeeSung Chul ChoiSoo-Jin ChoYoon-Ho ChoiYang Won MinByung-Hoon MinJun Haeng LeeMinwoong KangYeong Chan LeeJae J KimPublished in: Journal of gastroenterology and hepatology (2020)
This current national wide cohort study suggests that PPI use was associated with an increased risk of fatty liver disease compared with non-use of PPIs. Clinicians should consider fatty liver as a potential risk when prescribing PPI.